ALISSA FUGATE: Open Payments
NPI 1457878241 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 82 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $503 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $310 |
| ABBVIE INC. | 16 | $148 |
| Lilly USA, LLC | 8 | $146 |
| Amgen Inc. | 9 | $140 |
| Novo Nordisk Inc | 5 | $84 |
| Astellas Pharma US Inc | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Axsome Therapeutics, Inc. | 4 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Abbott Laboratories | 2 | $45 |
Products named: BREZTRI, JARDIANCE, OTEZLA, MOUNJARO, Veozah, VRAYLAR, REXULTI, Auvelity.
Industry payments across MO — which companies pay providers there.
